M S Hershfield
Overview
Explore the profile of M S Hershfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Betrains A, Staels F, Moens L, Delafontaine S, Hershfield M, Blockmans D, et al.
Scand J Rheumatol
. 2021 Feb;
50(6):493-496.
PMID: 33627040
No abstract available.
2.
Saito Y, Stamp L, Caudle K, Hershfield M, McDonagh E, Callaghan J, et al.
Clin Pharmacol Ther
. 2015 Jun;
99(1):36-7.
PMID: 26094938
The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B*58:01 Genotype and Allopurinol Dosing was originally published in February 2013. We reviewed the recent literature and concluded that none of the...
3.
Hershfield M, Callaghan J, Tassaneeyakul W, Mushiroda T, Thorn C, Klein T, et al.
Clin Pharmacol Ther
. 2012 Dec;
93(2):153-8.
PMID: 23232549
Allopurinol is the most commonly used drug for the treatment of hyperuricemia and gout. However, allopurinol is also one of the most common causes of severe cutaneous adverse reactions (SCARs),...
4.
Al-Saud B, Alsmadi O, Al-Muhsen S, Al-Ghonaium A, Al-Dhekri H, Arnaout R, et al.
Clin Biochem
. 2009 Sep;
42(16-17):1725-7.
PMID: 19733163
Background: Purine nucleoside phosphorylase (PNP) deficiency is an autosomal recessive disease in which affected children present with recurrent infection and may present with failure to thrive, neurological impairment, autoimmunity, or...
5.
Van De Wiel C, Hooker S, Laurent A, VAUGHN J, Blackburn M, Kellems R, et al.
Adv Exp Med Biol
. 2002 Jan;
486:65-70.
PMID: 11783529
No abstract available.
6.
Ariga T, Oda N, Yamaguchi K, Kawamura N, Kikuta H, Taniuchi S, et al.
Blood
. 2001 Apr;
97(9):2896-9.
PMID: 11313286
Inherited deficiency of adenosine deaminase (ADA) results in one of the autosomal recessive forms of severe combined immunodeficiency. This report discusses 2 patients with ADA deficiency from different families, in...
7.
Ariga T, Oda N, Sanstisteban I, Shioda M, Ueno H, Terada K, et al.
J Immunol
. 2001 Feb;
166(3):1698-702.
PMID: 11160213
Adenosine deaminase (ADA) deficiency causes an autosomal recessive form of severe combined immunodeficiency and also less severe phenotypes, depending to a large degree on genotype. In general, ADA activity in...
8.
Rubocki R, Parsa J, Hershfield M, Sanger W, Pirruccello S, Santisteban I, et al.
Blood
. 2001 Feb;
97(3):809-11.
PMID: 11157502
Bone marrow transplantation (BMT) for severe combined immunodeficiency (SCID) with human leukocyte antigen (HLA)-identical sibling donors but no pretransplantation cytoreduction results in T-lymphocyte engraftment and correction of immune dysfunction but...
9.
Richard E, Santisteban I, Kelly S, Patel D, Hershfield M
J Exp Med
. 2000 Nov;
192(9):1223-36.
PMID: 11067872
Human, but not murine, adenosine deaminase (ADA) forms a complex with the cell membrane protein CD26/dipeptidyl peptidase IV. CD26-bound ADA has been postulated to regulate extracellular adenosine levels and to...
10.
Thompson L, Van de Wiele C, Laurent A, Hooker S, VAUGHN J, Jiang H, et al.
J Clin Invest
. 2000 Nov;
106(9):1149-57.
PMID: 11067867
Murine fetal thymic organ culture was used to investigate the mechanism by which adenosine deaminase (ADA) deficiency causes T-cell immunodeficiency. C57BL/6 fetal thymuses treated with the specific ADA inhibitor 2'-deoxycoformycin...